2 Pot Stocks Ready for a Rebound in 2020

Cronos Group (TSX:CRON)(NASDAQ:CRON) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are ready to surge next year.

edit Jars of marijuana

Image source: Getty Images

Despite the recent pullback, marijuana stocks still have plenty of room left to run. On the first day of 2020, recreational pot will become legal in Illinois, adding another 13 million potential customers.

Several additional U.S. states are set to vote on legalization in the coming year. Depending on the federal election next November, country-wide legalization could soon be on the table.

Canada’s cannabis market also continues to heat up. This October, form factors like edibles and beverages were made legal. These new categories could ultimately add tens of billions of dollars in annual sales, yet due to the current bear market, many of these high-upside opportunities aren’t being priced in.

If you want to play the rebound in 2020, look no further than the following pot stocks.

These products are ready

There hasn’t been a ton of press regarding cannabis-infused edibles or beverages, as these products are more complicated than plain-old cannabis flowers.

They require more research and development, trickier regulatory paths, and more in-depth packaging and branding efforts. You may not see these market segment heat up until late 2020.

Only a handful of companies are capable of tapping this market early. Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be your best bet.

Last year, Canopy partnered with consumer giant Constellation Brands, Inc. in a multi-billion dollar deal, instantly making Canopy one of the most well-financed, best-positioned pot stocks on the market.

You may not know Constellation, but you certainly know many of its famous brands, including Corona and Modelo. The company is one of the largest alcohol distributors in the world.

With Constellation by its side, Canopy can leverage decades of experience and influence, something few other pot stocks can match. Highly regulated markets can be full of surprises, but Constellation has a proven record of execution.

Where the partnership ultimately heads is still in question, but if history is any indication, the Canopy-Constellation joint venture should result in big gains for shareholders.

Don’t count this company out

Canopy isn’t the only company with a high-powered partner. Last year, Cronos Group (TSX:CRON)(NASDAQ:CRON) agreed to become the exclusive cannabis partner of Altria Group Inc (NYSE:MO), which invested nearly $2 billion.

With a $100 billion market cap, Altria is one of the most successful tobacco companies in history. As with Constellation, Altria has a proven record of navigating highly regulated markets.

Over the decades, it’s captured half of the entire U.S. cigarette market, establishing powerhouse brands like Marlboro.

Canopy should capitalize on new market segments like THC-infused drinks. Cronos, meanwhile, should dominate more traditional markets such as dried flowers and vapes.

Altria brings big money and expertise, but also highly successful brands. In 2018, for example, Altria took a multi-billion position in vaping sensation Juul.

Rather than building its own cannabis brands from scratch, Cronos can now leverage trusted brands with worldwide reach. THC-based Juul or Marlboro products, for example, could be an instant success.

There are, of course, small pot stocks that could have even more upside, but when it comes to balancing the risk-reward trade-off, Cronos and Canopy should be at the top of your buy list.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »